Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
2018
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
2015
IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer
2019
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
2012
Hallmarks of cancer stem cell metabolism
2016
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
2012
Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
2010
Smarter drugs emerging in pancreatic cancer therapy
2014
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Pancreatic cancer
2004 Standout
Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer
2014
In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines
2011
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
To differentiate or not — routes towards metastasis
2012
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Cancer drug resistance: an evolving paradigm
2013 Standout
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate
2010
18F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer
2013
mTOR signaling and drug development in cancer
2010
Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness
2012
The biology and function of fibroblasts in cancer
2016 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics
2010
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer stem cells revisited
2017 Standout
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
2012
Colorectal cancer
2019 Standout
Cancer-associated cachexia
2018 Standout
Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway
2018
Extracellular matrix structure
2015 Standout
The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases
2014
Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells and Tumor
2018
Cancer stem cells: In the line of fire
2012
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
2014
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Cooperative Hedgehog-EGFR signaling
2011
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Surgical Management of Oligometastatic Non–Small Cell Lung Cancer
2016
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
TGF-β Tumor Suppression through a Lethal EMT
2016
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Sheep, wolf, or werewolf: Cancer stem cells and the epithelial-to-mesenchymal transition
2013
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
2014 Standout
Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by γ-Secretase Inhibitor IX
2012
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
2018 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Current treatment strategies for inhibiting mTOR in cancer
2014
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
2010
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Cancer stem cells: The challenges ahead
2013
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures
2012
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
2015
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
2014
Pancreatic cancer
2011 Standout
Pancreatic Cancer Stem Cells
2008
The Organocatalytic Approach to Enantiopure 2H‐ and 3H‐Pyrroles: Inhibitors of the Hedgehog Signaling Pathway
2016 StandoutNobel
The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1
2017
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
2012
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
2012
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Piezo1 channels restrain regulatory T cells but are dispensable for effector CD4 + T cell responses
2021 Standout
Combination therapy in combating cancer
2017 Standout
Colon Cancer Stem Cells: Promise of Targeted Therapy
2010
Organokatalytische Synthese von enantiomerenreinen 2H‐ und 3H‐Pyrrolen: Inhibitoren des Hedgehog‐Signalwegs
2016 StandoutNobel
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
2012
Mechanisms of chemoresistance in cancer stem cells
2013
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Biomimetic Nanobomb for Synergistic Therapy with Inhibition of Cancer Stem Cells
2023
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Works of M Mueller being referenced
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo
2009
Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
2009
Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
2011
Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment1
2004
Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
2012
Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction
2011